{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:53:49Z","timestamp":1790762029609,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/igc.0b013e31829783e3","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T07:09:39Z","timestamp":1370588979000},"page":"990-996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Alterations in Expression Pattern of Splicing Factors in Epithelial Ovarian Cancer and its Clinical Impact"],"prefix":"10.1016","volume":"23","author":[{"given":"Severine","family":"Iborra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hirschfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel zur","family":"Hausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona","family":"Braicu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Gitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Stickeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31829783e3_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0102-13","article-title":"A genomic view of alternative splicing","volume":"30","author":"Modrek","year":"2002","journal-title":"Nat Genet"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0010","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1093\/nar\/gkl498","article-title":"Defective splicing, disease and therapy: searching for master checkpoints in exon definition","volume":"34","author":"Buratti","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/PL00000687","article-title":"RNA processing and human disease","volume":"57","author":"Philips","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/104454902320908450","article-title":"Defects in pre-mRNA processing as causes of and predisposition to diseases","volume":"21","author":"Stoilov","year":"2002","journal-title":"DNA Cell Biol"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0025","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.1158\/0008-5472.CAN-04-1910","article-title":"Aberrant and alternative splicing in cancer","volume":"64","author":"Venables","year":"2004","journal-title":"Cancer Res"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0030","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1038\/sj.onc.1207362","article-title":"Identification of alternatively spliced mRNAvariants related to cancers by genome-wide ESTs alignment","volume":"23","author":"Hui","year":"2004","journal-title":"Oncogene"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gad.1048803","article-title":"Pre-mRNA splicing and human disease","volume":"17","author":"Faustino","year":"2003","journal-title":"Genes Dev"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0040","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1017\/S1355838200000960","article-title":"Sorting out the complexity of SR protein functions","volume":"6","author":"Graveley","year":"2000","journal-title":"RNA"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0045","first-page":"663","article-title":"The superfamily of arginine\/serine-rich splicing factors","volume":"1","author":"Fu","year":"1995","journal-title":"RNA"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-0-387-77374-2_7","article-title":"SR proteins and related factors in alternative splicing","volume":"623","author":"Lin","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0055","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/sj.onc.1202671","article-title":"Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis","volume":"18","author":"Stickeler","year":"1999","journal-title":"Oncogene"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0060","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/1541-7786.MCR-11-0156","article-title":"Understanding the dual nature of CD44 in breast cancer progression","volume":"9","author":"Louderbough","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0065","first-page":"4395","article-title":"Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer","volume":"17","author":"Stickeler","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0070","first-page":"1871","article-title":"Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines","volume":"17","author":"Stickeler","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0075","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-04-3294","article-title":"Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene","volume":"66","author":"Watermann","year":"2006","journal-title":"Cancer Res"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0080","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1093\/emboj\/20.14.3821","article-title":"The RNA binding protein YB-1 binds A\/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4","volume":"20","author":"Stickeler","year":"2001","journal-title":"EMBO J"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0085","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/bies.10300","article-title":"The pleiotropic functions of the Y-boxYbinding protein, YB-1","volume":"25","author":"Kohno","year":"2003","journal-title":"Bioessays"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0006-291X(02)00875-6","article-title":"Targeted disruption of one allele of the Y-box protein gene, Chk-YB-1b, in DT40 cells results in major defects in cell cycle","volume":"296","author":"Swamynathan","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0095","first-page":"5818","article-title":"Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas","volume":"58","author":"Ghigna","year":"1998","journal-title":"Cancer Res"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0100","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1158\/1535-7163.1485.3.11","article-title":"The role of nuclear Y-box binding protein 1 as a global marker in drug resistance","volume":"3","author":"Kuwano","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0105","first-page":"607","article-title":"Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer","volume":"26","author":"Huang","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2004.01.040","article-title":"Co-expression of Y boxYbinding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer","volume":"93","author":"Huang","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2003.tb01344.x","article-title":"The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies","volume":"94","author":"Kuwano","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00432-002-0386-6","article-title":"Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer","volume":"128","author":"Yahata","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1097\/IGC.0b013e31829783e3_bb0125","first-page":"1085","article-title":"Expression of splicing factors in human ovarian cancer","volume":"11","author":"Fischer","year":"2004","journal-title":"Oncol Rep"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2408767X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2408767X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:35:54Z","timestamp":1753223754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2408767X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1048891X2408767X"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31829783e3","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in Expression Pattern of Splicing Factors in Epithelial Ovarian Cancer and its Clinical Impact","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31829783e3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}